CTKB earnings: a positive outcome, +8.7%

On September 8, 2021, Cytek Biosciences, Inc. reached its earnings. The result was a positive outcome, and the stock moved +8.7% in the window around the event. It had already run -6.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.